Abstract
Introduction: Concomitant drug use is common among opioid-dependent patients in maintenance therapy. Attention deficit hyperactivity disorder (ADHD), a common comorbidity among opioid users, is associated with a higher risk of concomitant drug use. Earlier studies showed that methylphenidate (MPH) can reduce cocaine consumption among patients with ADHD. The use of MPH as an agonist-replacement or maintenance therapy in cocaine-dependent patients without ADHD is also common in Switzerland, despite a lack of supporting evidence. The aim of this study was to assess concomitant cocaine, amphetamine, MDMA, MPH, and heroin use among patients in opioid maintenance therapy either with or without comorbid ADHD. We expected stimulant consumption to be higher in patients with cocaine dependence and comorbid ADHD and that use of MPH would not lead to a reduction in cocaine consumption in patients without ADHD. We therefore evaluated correlations between use of MPH and cocaine consumption and between MPH consumption and cocaine craving within the two groups. Methods: This cross-sectional study included 94 opioid-dependent patients in maintenance therapy in an outpatient department of the Psychiatric Hospital of Zurich. The patients were divided into two groups based on comorbid ADHD; a group with ADHD (N = 27) and a group without ADHD (N = 67). Drug use was assessed using 3-month hair analysis. Results: We did not find significant differences in the number of patients using cocaine, amphetamine, MDMA, or heroin between groups with or without ADHD. With respect to cocaine use, 85.2 percent of patients in the ADHD group and 73.1 percent in the non-ADHD group were users. The non-ADHD group showed a significant positive correlation between the concentration of MPH and cocaine in hair samples (p < 0.05), and a positive correlation between cocaine craving and the concentration of MPH in hair samples (p = 0.065). These two trends were not evident in the ADHD group. Conclusion: Among patients without ADHD, use of MPH correlates with higher cocaine consumption and craving. Conversely, no significant correlation was found between MPH and cocaine use in patients with ADHD. Our study adds to the evidence that MPH confers negative effects in cocaine users without ADHD and should thus have no place in the treatment of these patients.
Journal Section:
Research Article
References
1.
van de Glind
G
, Konstenius
M
, Koeter
MWJ
, van Emmerik-van Oortmerssen
K
, Carpentier
PJ
, Kaye
S
. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria
. Drug Alcohol Depend
. 2014
;134
:158
–66
.2.
Schubiner
H
. Substance abuse in patients with attention-deficit hyperactivity disorder therapeutic implications
. CNS Drugs
. 2005
;19
(8
):643
–55
.3.
van de Glind
G
, Brynte
C
, Skutle
A
, Kaye
S
, Konstenius
M
, Levin
F
. The International Collaboration on ADHD and Substance Abuse (ICASA): mission, results, and future activities
. Eur Addict Res
. 2020
26
4–5
173
78
.4.
van Emmerik-van Oortmerssen
K
, van de Glind
G
, van den Brink
W
, Smit
F
, Crunelle
CL
, Swets
M
. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis
. Drug Alcohol Depend
. 2012
122
1–2
11
9
.5.
Volkow
ND
, Wang
G
, Kollins
SH
, Wigal
TL
, Newcorn
JH
, Telang
F
. Evaluating dopamine reward pathway in ADHD: clinical implications
. J Am Med Assoc
. 2009
;302
(10
):1084
–91
.6.
Young
SE
, Friedman
NP
, Miyake
A
, Willcutt
EG
, Corley
RP
, Haberstick
BC
. Behavioral disinhibition: liability for externalizing spectrum disorders and its genetic and environmental relation to response inhibition across adolescence
. J Abnorm Psychol
. 2009
;118
(1
):117
–30
.7.
Ashok
AH
, Mizuno
Y
, Volkow
ND
, Howes
OD
. Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine a systematic review and meta-analysis
. JAMA Psychiatry
. 2017
;74
(5
):511
–9
.8.
Khantzian
EJ
. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment
. Am J Psychiatry
. 1983
;140
(6
):784
–5
.9.
Calipari
ES
, Ferris
MJ
, Melchior
JR
, Bermejo
K
, Salahpour
A
, Roberts
DCS
. Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations
. Addict Biol
. 2014
;19
(2
):145
–55
.10.
Challman
TD
, Lipsky
JJ
. Methylphenidate: its pharmacology and uses
. Mayo Clin Proc
. 2000
;75
(7
):711
–21
.11.
Mariani
J
, Levin
FR
. Psychostimulant treatment of cocaine dependence
. Psychiatr Clin North Am
. 2012
;35
(2
):425
–39
.12.
Volkow
ND
, Wang
GJ
, Fowler
JS
, Fischman
M
, Foltin
R
, Abumrad
NN
. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain
. Life Sci
. 1999
65
1
PL7
P12
.13.
Dürsteler
KM
, Berger
EM
, Strasser
J
, Caflisch
C
, Mutschler
J
, Herdener
M
. Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence
. Subst Abuse Rehabil
. 2015
;6
:61
–74
.14.
Gorelick
DA
, Gardner
EL
, Xi
ZX
. Agents in development for the management of cocaine abuse
. Drugs
. 2004
;64
(14
):1547
–73
.15.
Rush
CR
, Stoops
WW
. Agonist replacement therapy for cocaine dependence: a translational review
. Future Med Chem
. 2012
;4
(2
):245
–65
.16.
Leonard
BE
, McCartan
D
, White
J
, King
DJ
. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects
. Hum Psychopharmacol
. 2004
;19
(3
):151
–80
.17.
Kollins
SH
, MacDonald
EK
, Rush
CR
. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review
. Pharmacol Biochem Behav
. 2001
;68
(3
):611
–27
.18.
Stoops
WW
, Glaser
PEA
, Fillmore
MT
, Rush
CR
. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans
. J Psychopharmacol
. 2004
;18
(4
):534
–43
.19.
Clemow
DB
. Misuse of methylphenidate
. Curr Top Behav Neurosci
. 2017
;34
:99
–124
.20.
Chan
B
, Kondo
K
, Freeman
M
, Ayers
C
, Montgomery
J
, Kansagara
D
. Pharmacotherapy for cocaine use disorder: a systematic review and meta-analysis
. J Gen Intern Med
. 2019
;34
(12
):2858
–73
.21.
Bentzley
BS
, Han
SS
, Neuner
S
, Humphreys
K
, Kampman
KM
, Halpern
CH
. Comparison of treatments for cocaine use disorder among adults: a systematic review and meta-analysis
. JAMA Netw Open
. 2021
;4
(5
):e218049
.22.
Fischer
B
, Blanken
P
, Da Silveira
D
, Gallassi
A
, Goldner
EM
, Rehm
J
. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies
. Int J Drug Policy
. 2015
;26
(4
):352
–63
.23.
Soyka
M
, Mutschler
J
. Treatment-refractory substance use disorder: focus on alcohol, opioids, and cocaine
. Prog Neuropsychopharmacol Biol Psychiatry
. 2016
;70
:148
–61
.24.
Collins
SL
, Levin
FR
, Foltin
RW
, Kleber
HD
, Evans
SM
. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD
. Drug Alcohol Depend
. 2006
;82
(2
):158
–67
.25.
Levin
FR
, Evans
SM
, McDowell
DM
, Kleber
HD
. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study
. J Clin Psychiatry
. 1998
;59
(6
):300
–5
.26.
Palis
H
, MacDonald
S
, Jun
J
, Oviedo-Joekes
E
. Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
. Harm Reduct J
. 2021
;18
(1
):57
.27.
Kampman
KM
. The treatment of cocaine use disorder
. Sci Adv
. 2019
5
10
eaax1532
.28.
Vogel
M
, Bucher
P
, Strasser
J
, Liechti
ME
, Krähenbühl
S
, Dürsteler
KM
. Similar and different? Subjective effects of methylphenidate and cocaine in opioid-maintained patients
. J Psychoactive Drugs
. 2016
;48
(2
):93
–100
.29.
Mutschler
J
, Gastberger
S
, Baumgartner
MR
, Grosshans
M
, Seifritz
E
, Quednow
BB
. Pregabalin use among opioid-addicted patients in Switzerland
. J Clin Psychiatry
. 2016
;77
(9
):1202
–3
.30.
Scholz
C
, Cabalzar
J
, Kraemer
T
, Baumgartner
MR
. A comprehensive multi-analyte method for hair analysis: substance-specific quantification ranges and tool for task-oriented data evaluation
. J Anal Toxicol
. 2021
;45
(7
):701
–12
.31.
Rosenberg
H
. Clinical and laboratory assessment of the subjective experience of drug craving
. Clin Psychol Rev
. 2009
;29
(6
):519
–34
.32.
Beck
AT
, Ward
CH
, Mendelson
M
, Mock
J
, Erbaugh
J
. An inventory for measuring depression
. Arch Gen Psychiatry
. 1961
;4
:561
–71
.33.
Spielberger
CD
, Gorsuch
RL
, Lushene
RE
, Vagg
PR
, Jacobs
GA
Manual for the state-trait anxiety inventory (form Y1 – Y2)
Palo Alto, CA
Consulting Psychologists Press
1983
.34.
Carroll
KM
, Rounsaville
BJ
. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers
. Compr Psychiatry
. 1993
;34
(2
):75
–82
.35.
Lee
SS
, Humphreys
KL
, Flory
K
, Liu
R
, Glass
K
. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review
. Clin Psychol Rev
. 2011
;31
(3
):328
–41
.36.
Lassi
DLS
, Malbergier
A
, Negrão
AB
, Florio
L
, De Aquino
JP
, Castaldelli-Maia
JM
. Pharmacological treatments for cocaine craving: what is the way forward? A systematic review
. Brain Sci
. 2022
;12
(11
):1546
.37.
Winhusen
T
, Somoza
E
, Singal
BM
, Harrer
J
, Apparaju
S
, Mezinskis
J
. Methylphenidate and cocaine: a placebo-controlled drug interaction study
. Pharmacol Biochem Behav
. 2006
;85
(1
):29
–38
.38.
Gawin
F
, Riordan
C
, Kleber
H
. Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report
. Am J Drug Alcohol Abuse
. 1985
11
3–4
193
7
.39.
Dürsteler-MacFarland
KM
, Farronato
NS
, Strasser
J
, Boss
J
, Kuntze
MF
, Petitjean
SA
. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription
. J Clin Psychopharmacol
. 2013
;33
(1
):104
–8
.40.
Grabowski
J
, Roache
JD
, Schmitz
JM
, Rhoades
H
, Creson
D
, Korszun
A
. Replacement medication for cocaine dependence: methylphenidate
. J Clin Psychopharmacol
. 1997
;17
(6
):485
–8
.41.
Levin
FR
, Evans
SM
, Brooks
DJ
, Garawi
F
. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo
. Drug Alcohol Depend
. 2007
;87
(1
):20
–9
.42.
Schubiner
H
, Saules
KK
, Arfken
CL
, Johanson
CE
, Schuster
CR
, Lockhart
N
. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence
. Exp Clin Psychopharmacol
. 2002
;10
(3
):286
–94
.43.
Moeller
SJ
, Konova
AB
, Tomasi
D
, Parvaz
MA
, Goldstein
RZ
. Abnormal response to methylphenidate across multiple fMRI procedures in cocaine use disorder: feasibility study
. Psychopharmacology
. 2016
;233
(13
):2559
–69
.44.
Chang
Z
, Lichtenstein
P
, Halldner
L
, D’Onofrio
B
, Serlachius
E
, Fazel
S
. Stimulant ADHD medication and risk for substance abuse
. J Child Psychol Psychiatry
. 2014
;55
(8
):878
–85
.45.
Wilens
TE
, Faraone
SV
, Biederman
J
, Gunawardene
S
. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
. Pediatrics
. 2003
;111
(1
):179
–85
.46.
Stoops
WW
, Rush
CR
. Agonist replacement for stimulant dependence: a review of clinical research
. Curr Pharm Des
. 2013
;19
(40
):7026
–35
.47.
Levin
FR
, Choi
CJ
, Pavlicova
M
, Mariani
JJ
, Mahony
A
, Brooks
DJ
. How treatment improvement in ADHD and cocaine dependence are related to one another: a secondary analysis
. Drug Alcohol Depend
. 2018
;188
:135
–40
.48.
Crunelle
CL
, van den Brink
W
, Moggi
F
, Konstenius
M
, Franck
J
, Levin
FR
. International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder
. Eur Addict Res
. 2018
;24
(1
):43
–51
.49.
Konstenius
M
, Jayaram-Lindström
N
, Guterstam
J
, Beck
O
, Philips
B
, Franck
J
. Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial
. Addiction
. 2014
;109
(3
):440
–9
.50.
Tardelli
VS
, Bisaga
A
, Arcadepani
FB
, Gerra
G
, Levin
FR
, Fidalgo
TM
. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
. Psychopharmacology
. 2020
;237
(8
):2233
–55
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
